Macrophage phenotype in induced sputum in asthma subjects;Fenotyp makrofagów w plwocinie indukowanej u chorych na astmȩ

Pneumonologia i Alergologia Polska

Volumn 74, Issue 1, 2006, Pages 101-105

  Hermanowicz Salamon, Joanna ^a   Domagała Kulawik, Joanna ^a   Maskey Warzȩchowska, Marta ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Asthma; Induced sputum; Macrophages

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD14 ANTIGEN; CD71 ANTIGEN; CELL SURFACE MARKER; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; PHENOTYPE; PROTEIN EXPRESSION; SPUTUM;

EID: 33745750812     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Balbo P. i wsp. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy 2001,31,625-636.
2. Belda J. i wsp. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med, 2000;161,475-478.
3. Cianchetti S. i wsp. Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects. Eur Respir J. 2004,24,1018-1024.
4. Domagała-Kulawik J. i wsp. The cellular composition and makrophage phenothype in induced suptum in smokers and ex-smokers with COPD. Chest, 2003;123,1054-1050.
5. Fadok V.A. i wsp. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest 1998 101,890-898.
6. Goto Y, H. i wsp. Particulate matter air pollution stimulates monocyte release from the bone marrow. A.JRCCM 2004; 170: 898-903.
7. Hermanowicz - Salamon i wsp. Wpływ palenia tytoniu na skład komórkowy i wybrane antygeny powierzchniowe makrofagów w plwocinie indukowanej. Magazyn Alergologiczny, 2005, 4.
8. Krombach F. i wsp. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J, 1996; 9, 984-991.
9. Lensmar C. i wsp. Airway inflammation and altered alveolar macrophage phenotype pattern after repeated low-dose allergen exposure of atopic asthmatic subjects. Clin Exp Allergy, 1999; 29, 1632-1640.
10. Lensmar C.G. i wsp. Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects. Eur Respir J, 1998;12,595-600.
11. Peters-Golden M. The alveolar macrophage. The forgotten cell in astma. Am. J. Respir. Cell Mol. Biol.2004,31,3-7.
12. Pizzichini E. i wsp. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J. Allergy Clin Immunol. 1997,99,539-544.
13. Pumputiene I. i wsp. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission. Allergy 2006, 61, 43-48.
14. Viksman M.Y. i wsp. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. Evidence for activation of alveolar macrophages , but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. Am J Respir Crit Care Med 1997,155,858-863.
15. Vissors J.L.M.i wsp. Macrophages induce an allergen specific and long-term suppression in a mouse asthma model. Eur Respir. J. 2005,26,1040-1046.
16. Wan C. T. i wsp. The human bone marrow response to acute air pollution caused by forest fires. AJRCCM, 2000; 161, 1213-1217.
17. Woodward I.E. i wsp. Anti-transferrin receptor monoclonal antibody: a novel immunosuppressant. Transplantation, 1998,65,6-9.